MYC-Driven Pathways in Breast Cancer Subtypes

por Fallah, Yassi, Brundage, Janetta, Allegakoen, Paul, Shajahan-Haq, Ayesha N.
Publicado en Biomolecules (2017)

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors

por Fallah, Yassi, Demas, Diane M., Jin, Lu, He, Wei, Shajahan-Haq, Ayesha N.
Publicado en Front Oncol (2021)

Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer

por Bakewell, Suzanne, Conde, Isabel, Fallah, Yassi, McCoy, Mathew, Jin, Lu, Shajahan-Haq, Ayesha N.
Publicado en Cancers (Basel) (2020)

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer

por Demas, Diane M., Demo, Susan, Fallah, Yassi, Clarke, Robert, Nephew, Kenneth P., Althouse, Sandra, Sandusky, George, He, Wei, Shajahan-Haq, Ayesha N.
Publicado en Front Oncol (2019)

Metabolomic biomarkers of pancreatic cancer: a meta-analysis study

por Mehta, Khyati Y., Wu, Hung-Jen, Menon, Smrithi S., Fallah, Yassi, Zhong, Xiaogang, Rizk, Nasser, Unger, Keith, Mapstone, Mark, Fiandaca, Massimo S., Federoff, Howard J., Cheema, Amrita K.
Publicado en Oncotarget (2017)